question_id,date,category,question_text,baseline_success,baseline_actually_answered,baseline_has_expected,baseline_confidence,baseline_text,baseline_error,baseline_time,baseline_input_tokens,baseline_output_tokens,togomcp_success,togomcp_has_expected,togomcp_confidence,togomcp_text,togomcp_error,togomcp_time,togomcp_input_tokens,togomcp_output_tokens,togomcp_cache_creation_input_tokens,togomcp_cache_read_input_tokens,tools_used,tool_details,value_add,expected_answer,notes
1,2026-02-01,Structured Query,Which human enzymes catalyze reactions that involve ATP as a substrate?,True,True,False,0.10526315789473684,"# Human Enzymes That Use ATP as a Substrate

ATP is one of the most common substrates in human metabolism. Hundreds of human enzymes use ATP, but they fall into several major functional categories:

## Major Enzyme Classes

### 1. **Kinases** (Phosphotransferases)
The largest group - these transfer phosphate from ATP to substrates:
- **Protein kinases** (>500 in humans) - phosphorylate proteins
- **Hexokinase** - phosphorylates glucose
- **Creatine kinase** - creates phosphocreatine
- **Pyruvate kinase** - glycolysis
- **Nucleoside kinases** - phosphorylate nucleosides

### 2. **Ligases**
Use ATP to form bonds between molecules:
- **DNA ligase** - joins DNA strands
- **Aminoacyl-tRNA synthetases** - attach amino acids to tRNAs
- **Acetyl-CoA synthetase** - forms acetyl-CoA
- **Carbamoyl phosphate synthetase** - urea cycle

### 3. **ATPases**
Hydrolyze ATP for various purposes:
- **Na+/K+-ATPase** - ion pump
- **Ca2+-ATPase** - calcium pump
- **H+-ATPase** - proton pump
- **Myosin** - muscle contraction
- **Helicases** - unwind DNA/RNA
- **ABC transporters** - transport molecules

### 4. **Adenylyl Cyclases**
Convert ATP to cyclic AMP (cAMP) for signaling

### 5. **ATP-dependent Proteases**
Use ATP for protein degradation (e.g., proteasome)

This represents hundreds of enzymes essential for metabolism, signaling, transport, and biosynthesis.",,9.185392141342163,52,440,True,False,0.2631578947368421,"Perfect! Now I have a comprehensive view of the types of human enzymes that use ATP. Let me provide you with a well-organized summary:

## Human Enzymes That Catalyze Reactions Involving ATP as a Substrate

Based on my search of biological databases, human enzymes that use ATP as a substrate can be categorized into several major functional classes:

### 1. **Kinases** (Phosphotransferases)
These enzymes transfer phosphate groups from ATP to substrates:

- **Protein kinases**: Cyclin-dependent kinases (CDK2, CDK5, CDK7, CDK9), tyrosine kinases (FGFR1, FLT3, FAK1, PTK2B), serine/threonine kinases (PLK1, PKA, PDK1), MAP kinase kinases (MEK1)
- **Nucleotide kinases**: Thymidylate kinase (EC 2.7.4.9), various nucleoside monophosphate and diphosphate kinases
- **Metabolic kinases**: Diacylglycerol kinase (EC 2.7.1.-), ceramide kinase (EC 2.7.1.138), inositol-tetrakisphosphate kinase (EC 2.7.1.134)

### 2. **Aminoacyl-tRNA Synthetases** (Ligases)
These enzymes attach amino acids to their corresponding tRNA molecules using ATP:

- Glycine--tRNA ligase (EC 6.1.1.14)
- Serine--tRNA ligase (EC 6.1.1.11)
- Lysine--tRNA ligase (EC 6.1.1.6)
- Glutamate--tRNA ligase (EC 6.1.1.17)
- Proline--tRNA ligase (EC 6.1.1.15)
- Threonine--tRNA ligase (EC 6.1.1.3)
- Methionine--tRNA ligase (EC 6.1.1.10)
- Cysteine--tRNA ligase (EC 6.1.1.16)
- Arginine--tRNA ligase (EC 6.1.1.19)
- Asparagine--tRNA ligase (EC 6.1.1.22)

### 3. **DNA/RNA Ligases**
- DNA ligase 1, 3, and 4 (EC 6.5.1.1) - seal DNA strand breaks
- Poly(A) polymerase gamma (EC 2.7.7.19) - adds adenine nucleotides to RNA

### 4. **ATPases and Ion Pumps**
These enzymes hydrolyze ATP to drive ion transport:

- **Na+/K+-ATPase** (EC 7.2.2.13) - maintains sodium and potassium gradients
- **Ca2+-ATPase** (EC 7.1.2.2) - pumps calcium ions
- **H+/K+-ATPase** (EC 7.2.2.19) - proton pumps in stomach
- **V-type proton ATPases** (EC 7.1.2.2) - acidify cellular compartments
- **ABC transporters** (EC 7.6.2.-) - transport various molecules across membranes

### 5. **Biosynthetic Enzymes (Synthetases/Synthases)**
- **ATP synthase** - produces ATP (also consumes ATP in reverse)
- **ATP-citrate synthase** (EC 2.3.3.8) - cleaves citrate using ATP
- **CTP synthase 1 & 2** (EC 6.3.4.2) - synthesizes CTP from UTP and ATP
- **Glutathione synthetase** (EC 6.3.2.3) - forms glutathione
- **Asparagine synthetase** (EC 6.3.5.4) - synthesizes asparagine
- **Sulfate adenylyltransferase** (EC 2.7.7.4) - activates sulfate

### 6. **Acyl-CoA Synthetases** (Fatty Acid Activators)
These convert fatty acids to acyl-CoA using ATP:
- Long-chain fatty acyl-CoA synthetase (EC 6.2.1.3)
- Medium-chain fatty acyl-CoA synthetase
- Short-chain fatty acyl-CoA synthetase
- Very long-chain fatty acyl-CoA synthetase

### 7. **ATP-Dependent Helicases and Chromatin Remodelers**
- DNA helicases (RecQ1, XPB, XPD) - unwind DNA
- RNA helicases (RENT1/UPF1) - unwind RNA
- Chromatin remodelers (CHD6) - remodel nucleosomes

### 8. **Ubiquitin/Ubiquitin-like Protein Activating Enzymes**
- Ubiquitin-activating enzyme E1
- SUMO-activating enzyme (SAE1/UBA2)
- NEDD8-activating enzyme
- UFM1-activating enzyme (UBA5)

### 9. **Metabolic Enzymes**
- **Phosphoenolpyruvate carboxykinase** (EC 4.1.1.32) - gluconeogenesis
- **5-oxoprolinase** (EC 3.5.2.9) - glutathione metabolism
- **Firefly luciferase** (EC 1.13.12.7) - produces light using ATP

### Key Reaction Types:
1. **Phosphorylation**: ATP + Substrate → ADP + Phospho-substrate
2. **Adenylation/Ligation**: ATP + Substrates → AMP + PPi + Product
3. **Active Transport**: ATP + H₂O → ADP + Pi (coupled to ion movement)
4. **Conformational Changes**: ATP binding/hydrolysis drives molecular motors

These enzymes are essential for virtually all cellular processes including energy metabolism, biosynthesis, signal transduction, DNA/RNA processing, protein synthesis, and active transport.",,69.791024684906,24,2621,41630,93421,"mcp__togomcp__search_rhea_entity, mcp__togomcp__search_uniprot_entity, mcp__togomcp__run_sparql, mcp__togomcp__run_sparql, mcp__togomcp__search_uniprot_entity, mcp__togomcp__search_uniprot_entity, mcp__togomcp__search_uniprot_entity, mcp__togomcp__search_uniprot_entity","[{""name"": ""mcp__togomcp__search_rhea_entity"", ""input"": {""query"": ""ATP"", ""limit"": 100}}, {""name"": ""mcp__togomcp__search_uniprot_entity"", ""input"": {""query"": ""human ATP binding enzyme"", ""limit"": 20}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""uniprot"", ""sparql_query"": ""PREFIX up: <http://purl.uniprot.org/core/>\nPREFIX rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX taxon: <http://purl.uniprot.org/taxonomy/>\nPREFIX chebi: <http://purl.uniprot.org/chebi/>\n\nSELECT DISTINCT ?protein ?proteinName ?ecName\nWHERE {\n  ?protein a up:Protein ;\n           up:organism taxon:9606 ;\n           up:recommendedName ?recName ;\n           up:enzyme ?enzyme .\n  ?recName up:fullName ?proteinName .\n  ?enzyme up:ecName ?ecName .\n  ?protein up:annotation ?annotation .\n  ?annotation a up:Catalytic_Activity_Annotation ;\n              up:catalyticActivity ?activity .\n  ?activity up:catalyzedReaction ?reaction .\n  ?reaction rdfs:comment ?comment .\n  FILTER(CONTAINS(LCASE(?comment), \""atp\""))\n}\nLIMIT 100""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""rhea"", ""sparql_query"": ""PREFIX rh: <http://rdf.rhea-db.org/>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX chebi: <http://purl.obolibrary.org/obo/>\n\nSELECT DISTINCT ?reaction ?equation ?ec\nWHERE {\n  ?reaction rh:equation ?equation ;\n            rh:ec ?ec .\n  ?reaction rh:side ?side .\n  ?side rh:contains ?participant .\n  ?participant rh:compound chebi:CHEBI_30616 .\n  FILTER(CONTAINS(?equation, \""ATP\""))\n}\nLIMIT 50""}}, {""name"": ""mcp__togomcp__search_uniprot_entity"", ""input"": {""query"": ""human kinase ATP"", ""limit"": 20}}, {""name"": ""mcp__togomcp__search_uniprot_entity"", ""input"": {""query"": ""human ATPase"", ""limit"": 20}}, {""name"": ""mcp__togomcp__search_uniprot_entity"", ""input"": {""query"": ""human synthetase ATP"", ""limit"": 20}}, {""name"": ""mcp__togomcp__search_uniprot_entity"", ""input"": {""query"": ""human ligase ATP"", ""limit"": 20}}]",VALUABLE,"List of UniProt protein IDs with their names and associated Rhea reaction IDs, such as P09979 (Hygromycin-B 7''-O-kinase), Q9D5J6 (Sedoheptulokinase), P54645 (AMP-activated protein kinase)","COMPLEX QUERY requiring cross-database knowledge.

Databases/Resources: UniProt (proteins/enzymes), Rhea (biochemical reactions)

Knowledge Required:
- UniProt and Rhea GRAPH URIs on shared SIB endpoint
- Pre-filtering with up:reviewed 1 essential (444M vs 923K proteins)
- EC number linkage via up:enzyme and rhea:ec
- bif:contains for ATP search in reaction equations
- rhea:status rhea:Approved for quality reactions

Without proper knowledge: Query times out processing entire protein database before filtering.

Verified in uniprot_exploration.md Pattern 1 and rhea_exploration.md Pattern 1."
2,2026-02-01,Structured Query,Find human proteins whose recommended name contains the word 'kinase'.,True,True,False,0.29411764705882354,"I can help you find human proteins whose recommended names contain the word ""kinase.""

Based on my training knowledge, there are thousands of human proteins with ""kinase"" in their recommended names. Kinases are enzymes that catalyze the transfer of phosphate groups from high-energy donor molecules (like ATP) to specific substrates. Here are some major categories and examples:

## Major Kinase Families:

**Protein Kinases:**
- Protein kinase A (PKA/cAMP-dependent protein kinase)
- Protein kinase B (AKT)
- Protein kinase C (PKC) - multiple isoforms (α, β, γ, δ, ε, etc.)
- Mitogen-activated protein kinases (MAPK family)
- Cyclin-dependent kinases (CDK1, CDK2, CDK4, CDK6, etc.)

**Tyrosine Kinases:**
- Epidermal growth factor receptor kinase (EGFR)
- Janus kinases (JAK1, JAK2, JAK3, TYK2)
- Src family kinases
- Bruton's tyrosine kinase (BTK)

**Serine/Threonine Kinases:**
- Glycogen synthase kinase-3 (GSK-3)
- Aurora kinases (Aurora A, B, C)
- Polo-like kinases (PLK1-4)

**Other Kinases:**
- Creatine kinase
- Pyruvate kinase
- Hexokinase
- Adenylate kinase

The human kinome contains approximately **518 protein kinases**, making it one of the largest protein families. Would you like more specific information about any particular kinase family or type?",,7.84353494644165,51,417,True,False,0.4117647058823529,"Great! I found many human proteins with ""kinase"" in their recommended names. Here's a sample of the results (showing 100 out of potentially many more):

## Human Proteins with ""Kinase"" in Recommended Name

The search identified numerous human proteins including:

**Protein Kinases:**
- **cAMP-dependent protein kinase catalytic subunit alpha** (P17612)
- **cAMP-dependent protein kinase type II-beta regulatory subunit** (P31323)
- **Receptor-interacting serine/threonine-protein kinase 3** (Q9Y572)
- **Rho-associated protein kinase 1** (A0A0U1RQV4)
- **Testis-specific serine/threonine-protein kinase 4** (Q6SA08)
- **Mitogen-activated protein kinase kinase kinase kinase 1** (Q92918)
- **Cyclin-dependent kinase 14** (E7EUK8)
- **Stress-activated protein kinase JNK** (D7R525)

**Other Kinases:**
- **Casein kinase II subunit alpha'-interacting protein** (A0A1B0GTH6)
- **Pyruvate kinase** (multiple isoforms)
- **Phosphoenolpyruvate carboxykinase [GTP], mitochondrial** (Q16822)
- **Acylglycerol kinase, mitochondrial** (multiple isoforms)
- **NAD(+) kinase** (A0A0A0MR98)
- **Nucleoside-diphosphate kinase** (multiple isoforms)
- **6-phosphofructokinase type C** (B1APP6)
- **Phosphorylase b kinase regulatory subunit** (A6NIT2, A6NMN0)

**Kinase-interacting proteins:**
- **p21-activated protein kinase-interacting protein 1** (Q9NWT1)
- **IkappaB kinase complex-associated protein** (multiple isoforms)
- **Inhibitor of Bruton tyrosine kinase** (Q9P2D0)

The results include many types of kinases involved in phosphorylation (serine/threonine, tyrosine, dual-specificity), metabolic kinases, and regulatory kinase subunits. The limit was set to 100 results, but there are likely many more human kinases in the UniProt database.",,22.304214000701904,9,889,4642,52262,mcp__togomcp__run_sparql,"[{""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""uniprot"", ""sparql_query"": ""\nPREFIX up: <http://purl.uniprot.org/core/>\nPREFIX taxon: <http://purl.uniprot.org/taxonomy/>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\n\nSELECT DISTINCT ?protein ?proteinLabel ?recommendedName\nWHERE {\n  ?protein a up:Protein ;\n           up:organism taxon:9606 ;\n           up:recommendedName ?recName .\n  \n  ?recName up:fullName ?recommendedName .\n  \n  FILTER(CONTAINS(LCASE(?recommendedName), \""kinase\""))\n  \n  OPTIONAL { ?protein rdfs:label ?proteinLabel }\n}\nLIMIT 100\n""}}]",VALUABLE,"List of human kinase proteins such as Q9FIZ3 (LRR receptor-like serine/threonine-protein kinase GSO2), Q04982 (Serine/threonine-protein kinase B-raf), and many others","COMPLEX QUERY requiring error-avoidance knowledge.

Databases/Resources: UniProt

Knowledge Required:
- Property path splitting for bif:contains (critical)
- bif:contains cannot be combined with property paths like up:recommendedName/up:fullName
- Must split into: up:recommendedName ?name . ?name up:fullName ?fullName
- up:reviewed 1 filter for performance
- Organism filter for human proteins

Without proper knowledge: Query fails with 400 Bad Request error due to bif:contains incompatibility with property paths.

Verified in uniprot_exploration.md Pattern 2 (bif:contains with Split Property Path)."
3,2026-02-01,Integration,What human proteins are involved in membrane transport and have associated biochemical reaction equations?,True,True,False,0.35,"Based on my training knowledge, here are some key human membrane transport proteins with associated biochemical reaction equations:

## 1. **Sodium-Potassium ATPase (Na+/K+-ATPase)**
- **Reaction**: 3Na+(in) + 2K+(out) + ATP + H2O → 3Na+(out) + 2K+(in) + ADP + Pi
- Primary active transporter maintaining cellular ion gradients

## 2. **SERCA (Sarco/Endoplasmic Reticulum Ca2+-ATPase)**
- **Reaction**: 2Ca2+(cytosol) + ATP + H2O → 2Ca2+(ER lumen) + ADP + Pi
- Pumps calcium into the ER/SR

## 3. **Sodium-Glucose Cotransporter (SGLT1/SGLT2)**
- **Reaction**: Na+(out) + Glucose(out) → Na+(in) + Glucose(in)
- Secondary active transport in intestine and kidney

## 4. **Proton-ATPase (H+-ATPase/V-ATPase)**
- **Reaction**: ATP + H2O + H+(in) → ADP + Pi + H+(out)
- Acidifies compartments like lysosomes and endosomes

## 5. **ABC Transporters** (e.g., CFTR, MDR1/P-glycoprotein)
- **General reaction**: Substrate(in) + ATP → Substrate(out) + ADP + Pi
- ATP-dependent efflux of various molecules

## 6. **Sodium-Calcium Exchanger (NCX)**
- **Reaction**: 3Na+(out) + Ca2+(in) → 3Na+(in) + Ca2+(out)
- Electrogenic antiporter

These equations represent the stoichiometry of transport and energy coupling involved in moving substances across biological membranes.",,10.324854850769043,53,461,True,True,0.65,"Excellent! Now I have comprehensive data. Let me compile this information into a clear answer for the user.

Based on my search of biological databases, I've identified several categories of human membrane transport proteins with associated biochemical reaction equations:

## **1. Calcium-Transporting ATPases (P-type Ca²⁺ transporters)**

These proteins actively pump calcium ions across membranes using ATP hydrolysis:

- **Plasma membrane calcium-transporting ATPase 1 (PMCA1)** - P20020
- **Plasma membrane calcium-transporting ATPase 3 (PMCA3)** - Q16720
- **Plasma membrane calcium-transporting ATPase 4 (PMCA4)** - P23634
- **Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2)** - A0A0S2Z3L2
- **Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3)** - Q93084
- **Calcium-transporting ATPase type 2C member 1** - H0Y9V7, P98194
- **Calcium-transporting ATPase type 2C member 2** - O75185

**Reactions:**
- `ATP + Ca²⁺(in) + H₂O = ADP + Ca²⁺(out) + H⁺ + phosphate`
- `ATP + H₂O + Mn²⁺(in) = ADP + H⁺ + Mn²⁺(out) + phosphate` (also transports manganese)

## **2. Sodium/Potassium-Transporting ATPases (Na⁺/K⁺-exchanging ATPases)**

- **Sodium/potassium-transporting ATPase subunit alpha-2** - P50993
- **Potassium-transporting ATPase alpha chain 2** - P54707

**Reactions:**
- `ATP + H₂O + K⁺(out) + Na⁺(in) = ADP + H⁺ + K⁺(in) + Na⁺(out) + phosphate`
- `ATP + H⁺(in) + H₂O + K⁺(out) = ADP + 2 H⁺(out) + K⁺(in) + phosphate`

## **3. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)**

- **CFTR** - P13569, A0A3B3ITE0, A0A3B3ITW5, E7EPB6

**Reactions:**
- `ATP + H₂O = ADP + H⁺ + phosphate` (ATP hydrolysis for gating)
- `chloride(in) = chloride(out)` (chloride transport)
- `hydrogencarbonate(in) = hydrogencarbonate(out)` (bicarbonate transport)

## **4. Phospholipid-Transporting ATPases (Flippases)**

- **Phospholipid-transporting ATPase IH** - P98196
- **Phospholipid-transporting ATPase IF** - Q9Y2G3
- **Phospholipid-transporting ATPase ABCA7** - Q8IZY2
- **Phosphatidylcholine translocator ABCB4** - P21439

**Reactions:**
- `a 1,2-diacyl-sn-glycero-3-phospho-L-serine(out) + ATP + H₂O = a 1,2-diacyl-sn-glycero-3-phospho-L-serine(in) + ADP + H⁺ + phosphate`
- `a 1,2-diacyl-sn-glycero-3-phosphoethanolamine(out) + ATP + H₂O = a 1,2-diacyl-sn-glycero-3-phosphoethanolamine(in) + ADP + H⁺ + phosphate`
- `a 1,2-diacyl-sn-glycero-3-phosphocholine(in) + ATP + H₂O = a 1,2-diacyl-sn-glycero-3-phosphocholine(out) + ADP + H⁺ + phosphate`
- `a sphingomyelin(in) + ATP + H₂O = a sphingomyelin(out) + ADP + H⁺ + phosphate`

## **5. ABC-Type Xenobiotic and Glutathione-S-Conjugate Transporters**

- **RalA-binding protein 1 (RALBP1)** - Q15311
- **ATP-binding cassette sub-family B member 5** - Q2M3G0
- **ABC-type antigen peptide transporters** - A0A087WYD6, A0A0G2JLV0, A0A140T9T7, A0A140T9S0

**Reactions:**
- `ATP + H₂O + leukotriene C4(in) = ADP + H⁺ + leukotriene C4(out) + phosphate`
- `an S-substituted glutathione(in) + ATP + H₂O = ADP + an S-substituted glutathione(out) + H⁺ + phosphate`
- `ATP + daunorubicin(in) + H₂O = ADP + daunorubicin(out) + H⁺ + phosphate`
- `a peptide antigen(in) + ATP + H₂O = a peptide antigen(out) + ADP + H⁺ + phosphate`

## **6. Plasma Membrane Ascorbate-Dependent Reductase**

- **CYBRD1** - C9JML1

**Reactions:**
- `Fe³⁺(out) + L-ascorbate(in) = Fe²⁺(out) + H⁺ + monodehydro-L-ascorbate radical(in)`
- `Cu²⁺(out) + L-ascorbate(in) = Cu⁺(out) + H⁺ + monodehydro-L-ascorbate radical(in)`
- `L-ascorbate(in) + monodehydro-L-ascorbate radical(out) = L-ascorbate(out) + monodehydro-L-ascorbate radical(in)`

## **7. Other Transporters with Associated Reactions**

From Rhea database, additional membrane transport reactions include:

- **Sodium-calcium exchangers**: `Ca²⁺(in) + Na⁺(out) = Ca²⁺(out) + Na⁺(in)`
- **Calcium-proton exchangers**: `Ca²⁺(in) + H⁺(out) = Ca²⁺(out) + H⁺(in)`
- **Na⁺/K⁺/2Cl⁻ cotransporter**: `K⁺(out) + 2 chloride(out) + Na⁺(out) = K⁺(in) + 2 chloride(in) + Na⁺(in)`

These proteins play critical roles in maintaining ion homeostasis, drug detoxification, lipid asymmetry in membranes, and nutrient transport across cellular membranes.",,126.8823630809784,52,4704,28212,303179,"mcp__togomcp__search_uniprot_entity, mcp__ols__searchClasses, mcp__togomcp__search_rhea_entity, mcp__togomcp__search_rhea_entity, mcp__togomcp__search_rhea_entity, mcp__togomcp__run_sparql, mcp__togomcp__search_rhea_entity, mcp__togomcp__run_sparql, mcp__togomcp__search_rhea_entity, mcp__togomcp__run_sparql, mcp__togomcp__search_rhea_entity, mcp__togomcp__run_sparql, mcp__togomcp__search_rhea_entity, mcp__togomcp__search_rhea_entity, mcp__togomcp__search_rhea_entity, mcp__togomcp__run_sparql","[{""name"": ""mcp__togomcp__search_uniprot_entity"", ""input"": {""query"": ""human membrane transport protein"", ""limit"": 20}}, {""name"": ""mcp__ols__searchClasses"", ""input"": {""query"": ""membrane transport"", ""pageSize"": 10}}, {""name"": ""mcp__togomcp__search_rhea_entity"", ""input"": {""query"": ""calcium ATPase membrane"", ""limit"": 20}}, {""name"": ""mcp__togomcp__search_rhea_entity"", ""input"": {""query"": ""sodium bile acid cotransporter"", ""limit"": 20}}, {""name"": ""mcp__togomcp__search_rhea_entity"", ""input"": {""query"": ""phosphate transport mitochondrial"", ""limit"": 20}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""uniprot"", ""sparql_query"": ""PREFIX up: <http://purl.uniprot.org/core/>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX taxon: <http://purl.uniprot.org/taxonomy/>\n\nSELECT DISTINCT ?protein ?proteinName ?function\nWHERE {\n  ?protein a up:Protein ;\n           up:organism taxon:9606 ;\n           up:recommendedName ?recName ;\n           up:annotation ?annotation .\n  ?recName up:fullName ?proteinName .\n  ?annotation a up:Function_Annotation ;\n              rdfs:comment ?function .\n  FILTER (\n    CONTAINS(LCASE(?function), \""membrane\"") && \n    CONTAINS(LCASE(?function), \""transport\"")\n  )\n}\nLIMIT 15""}}, {""name"": ""mcp__togomcp__search_rhea_entity"", ""input"": {""query"": ""ATP phosphate transport"", ""limit"": 20}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""uniprot"", ""sparql_query"": ""PREFIX up: <http://purl.uniprot.org/core/>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX taxon: <http://purl.uniprot.org/taxonomy/>\nPREFIX skos: <http://www.w3.org/2004/02/skos/core#>\n\nSELECT DISTINCT ?protein ?proteinName ?ecName ?catalyticActivity\nWHERE {\n  ?protein a up:Protein ;\n           up:organism taxon:9606 ;\n           up:recommendedName ?recName ;\n           up:enzyme ?enzyme ;\n           up:annotation ?annotation .\n  ?recName up:fullName ?proteinName .\n  ?enzyme up:activity ?activity ;\n          skos:prefLabel ?ecName .\n  ?annotation a up:Catalytic_Activity_Annotation ;\n              up:catalyticActivity ?catAct .\n  ?catAct up:catalyzedReaction ?reaction .\n  ?reaction rdfs:label ?catalyticActivity .\n  FILTER (\n    CONTAINS(LCASE(?proteinName), \""membrane\"") || \n    CONTAINS(LCASE(?proteinName), \""transport\"")\n  )\n}\nLIMIT 20""}}, {""name"": ""mcp__togomcp__search_rhea_entity"", ""input"": {""query"": ""calcium"", ""limit"": 30}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""uniprot"", ""sparql_query"": ""PREFIX up: <http://purl.uniprot.org/core/>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX taxon: <http://purl.uniprot.org/taxonomy/>\nPREFIX skos: <http://www.w3.org/2004/02/skos/core#>\n\nSELECT DISTINCT ?protein ?proteinName ?ecName ?catalyticActivity\nWHERE {\n  ?protein a up:Protein ;\n           up:organism taxon:9606 ;\n           up:recommendedName ?recName ;\n           up:enzyme ?enzyme ;\n           up:annotation ?annotation .\n  ?recName up:fullName ?proteinName .\n  ?enzyme up:activity ?activity ;\n          skos:prefLabel ?ecName .\n  ?annotation a up:Catalytic_Activity_Annotation ;\n              up:catalyticActivity ?catAct .\n  ?catAct up:catalyzedReaction ?reaction .\n  ?reaction rdfs:label ?catalyticActivity .\n  FILTER (\n    CONTAINS(LCASE(?proteinName), \""atpase\"") ||\n    CONTAINS(LCASE(?proteinName), \""transporter\"") ||\n    CONTAINS(LCASE(?proteinName), \""exchanger\"") ||\n    CONTAINS(LCASE(?proteinName), \""carrier\"")\n  )\n}\nLIMIT 30""}}, {""name"": ""mcp__togomcp__search_rhea_entity"", ""input"": {""query"": ""sodium potassium"", ""limit"": 20}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""uniprot"", ""sparql_query"": ""PREFIX up: <http://purl.uniprot.org/core/>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX taxon: <http://purl.uniprot.org/taxonomy/>\nPREFIX skos: <http://www.w3.org/2004/02/skos/core#>\n\nSELECT DISTINCT ?protein ?proteinName ?ecName ?catalyticActivity\nWHERE {\n  ?protein a up:Protein ;\n           up:organism taxon:9606 ;\n           up:recommendedName ?recName ;\n           up:enzyme ?enzyme ;\n           up:annotation ?annotation .\n  ?recName up:fullName ?proteinName .\n  ?enzyme up:activity ?activity ;\n          skos:prefLabel ?ecName .\n  ?annotation a up:Catalytic_Activity_Annotation ;\n              up:catalyticActivity ?catAct .\n  ?catAct up:catalyzedReaction ?reaction .\n  ?reaction rdfs:label ?catalyticActivity .\n  FILTER (\n    CONTAINS(LCASE(?proteinName), \""solute carrier\"") ||\n    CONTAINS(LCASE(?proteinName), \""abc transporter\"") ||\n    CONTAINS(LCASE(?proteinName), \""sodium/\"")\n  )\n}\nLIMIT 30""}}, {""name"": ""mcp__togomcp__search_rhea_entity"", ""input"": {""query"": ""glucose transport"", ""limit"": 15}}, {""name"": ""mcp__togomcp__search_rhea_entity"", ""input"": {""query"": ""ABC transporter ATP"", ""limit"": 20}}, {""name"": ""mcp__togomcp__search_rhea_entity"", ""input"": {""query"": ""proton pump"", ""limit"": 15}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""uniprot"", ""sparql_query"": ""PREFIX up: <http://purl.uniprot.org/core/>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX taxon: <http://purl.uniprot.org/taxonomy/>\nPREFIX skos: <http://www.w3.org/2004/02/skos/core#>\n\nSELECT DISTINCT ?protein ?proteinName ?ecName ?catalyticActivity\nWHERE {\n  ?protein a up:Protein ;\n           up:organism taxon:9606 ;\n           up:recommendedName ?recName ;\n           up:enzyme ?enzyme ;\n           up:annotation ?annotation .\n  ?recName up:fullName ?proteinName .\n  ?enzyme up:activity ?activity ;\n          skos:prefLabel ?ecName .\n  ?annotation a up:Catalytic_Activity_Annotation ;\n              up:catalyticActivity ?catAct .\n  ?catAct up:catalyzedReaction ?reaction .\n  ?reaction rdfs:label ?catalyticActivity .\n  FILTER (\n    CONTAINS(LCASE(?ecName), \""abc\"") ||\n    CONTAINS(LCASE(?ecName), \""transporter\"")\n  )\n}\nLIMIT 25""}}]",CRITICAL,"List of human transport enzymes with their Rhea reaction equations, such as P54707 (Potassium-transporting ATPase alpha chain 2), P20648 (Potassium-transporting ATPase alpha chain 1)","COMPLEX QUERY requiring cross-database knowledge.

Databases/Resources: UniProt (proteins), Rhea (reactions)

Knowledge Required:
- rhea:isTransport 1 filter for transport reactions
- Cross-database join via EC numbers
- up:reviewed 1 filter essential
- Organism filter for human proteins
- Both GRAPH clauses required on shared SIB endpoint

Without proper knowledge: Query timeout or incorrect results from missing transport filter or reviewed filter.

Verified in rhea_exploration.md Pattern 2 (Human Transport Enzyme Discovery)."
4,2026-02-01,Integration,How can I map UniProt protein P04637 to its corresponding gene in NCBI Gene database?,True,False,True,0.8,"To map UniProt protein P04637 to its corresponding NCBI Gene entry, you can use several approaches:

## Direct Methods:

1. **UniProt Entry Page**
   - Go to the UniProt entry for P04637
   - Look in the ""Cross-references"" section
   - Find the ""GeneID"" subsection under ""Gene expression databases""
   - This will show the NCBI Gene database ID

2. **UniProt ID Mapping Tool**
   - Use UniProt's ID mapping service at uniprot.org/id-mapping
   - Input P04637 as the source ID
   - Select ""From: UniProtKB AC/ID"" and ""To: GeneID""
   - This will return the corresponding NCBI Gene ID

## What You'll Find:

For **P04637** specifically, this is the human tumor protein p53 (TP53), which maps to:
- **NCBI Gene ID: 7157**
- **Gene Symbol: TP53**
- **Official Name: tumor protein p53**

## Alternative Approaches:

3. **NCBI Gene Search**
   - Search NCBI Gene database directly using the gene symbol from UniProt
   - Verify the match using protein accession numbers listed in NCBI Gene

4. **Programmatic Access**
   - Use UniProt REST API
   - Use NCBI E-utilities to cross-reference

The most reliable method is checking the cross-references directly in the UniProt entry, as these are curated mappings maintained by both databases.",,9.034747123718262,60,364,True,True,0.6,"Perfect! The UniProt protein **P04637** maps to **NCBI Gene ID: 7157**.

This is the **TP53 gene** (Tumor Protein P53), which encodes the p53 protein - a crucial tumor suppressor that plays a major role in preventing cancer by regulating cell cycle and inducing apoptosis in response to DNA damage.

If you need more information about this gene or want to perform additional ID conversions, just let me know!",,15.841202020645142,8,228,479,52271,mcp__togomcp__togoid_convertId,"[{""name"": ""mcp__togomcp__togoid_convertId"", ""input"": {""ids"": ""P04637"", ""route"": ""uniprot,ncbigene""}}]",CRITICAL,NCBI Gene ID 7157 (TP53 gene),"COMPLEX QUERY requiring ID conversion knowledge.

Databases/Resources: UniProt, NCBI Gene (via TogoID)

Knowledge Required:
- TogoID route configuration: 'uniprot,ncbigene'
- Understanding of protein-to-gene relationship
- Validation that mapping exists
- Alternative SPARQL approach via UniProt cross-references

Without proper knowledge: Cannot determine correct route or alternative approaches.

Verified in uniprot_exploration.md simple queries section and togoid documentation."
5,2026-02-01,Completeness,How many reviewed human proteins are recorded in UniProt?,True,False,True,1.0,"I don't have access to the current, real-time number of reviewed human proteins in UniProt. 

However, I can tell you that:

1. **UniProt/Swiss-Prot** contains the manually reviewed and annotated protein entries (the ""reviewed"" set)
2. **UniProt/TrEMBLE** contains the automatically annotated entries (the ""unreviewed"" set)

Based on my training data, the number of reviewed human proteins in UniProt/Swiss-Prot was approximately **20,000-21,000 entries**. This number has been growing gradually over time as more proteins are manually reviewed and annotated.

For the most current and accurate count, you would need to check the UniProt website directly (uniprot.org), where they provide up-to-date statistics for each species, including humans (taxonomy ID: 9606).",,5.47907280921936,49,200,True,True,1.0,"According to UniProt, there are **20,435 reviewed human proteins** recorded in the database.

These reviewed proteins are part of UniProtKB/Swiss-Prot, which is the manually annotated and reviewed section of UniProt. These entries have been curated by experts and contain high-quality, non-redundant protein sequence and functional information for human (Homo sapiens, taxonomy ID: 9606).",,13.143059015274048,9,286,545,52260,mcp__togomcp__run_sparql,"[{""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""uniprot"", ""sparql_query"": ""\nPREFIX up: <http://purl.uniprot.org/core/>\nPREFIX taxon: <http://purl.uniprot.org/taxonomy/>\n\nSELECT (COUNT(DISTINCT ?protein) AS ?count)\nWHERE {\n  ?protein a up:Protein ;\n           up:reviewed true ;\n           up:organism taxon:9606 .\n}\n""}}]",CRITICAL,"40,209 reviewed human proteins","COMPLEX QUERY requiring performance knowledge.

Databases/Resources: UniProt

Knowledge Required:
- up:reviewed 1 filter is CRITICAL (reduces 444M to 923K)
- Organism filter via taxonomy URI
- Proper COUNT pattern

Without proper knowledge: Query times out trying to count all 444M proteins, or returns incorrect count including unreviewed proteins (313,564).

Verified in uniprot_exploration.md Pattern 4 (Performance-Critical COUNT Query)."
6,2026-02-01,Completeness,How many descendant terms does the Gene Ontology term 'autophagy' (GO:0006914) have?,True,False,True,1.0,"I don't have access to real-time Gene Ontology database information, so I cannot provide you with the exact current number of descendant terms for GO:0006914 (autophagy).

The Gene Ontology is regularly updated with new terms and relationships, so the number of descendant terms changes over time as the ontology is refined and expanded. Autophagy is a well-studied biological process with many specific subtypes and related processes, so it likely has a substantial number of descendant terms including various types of autophagy (macroautophagy, microautophagy, chaperone-mediated autophagy, etc.) and their regulation.

To get the current accurate count, you would need to:
1. Query the Gene Ontology database directly at geneontology.org
2. Use tools like AmiGO, QuickGO, or the GO API
3. Use bioinformatics packages like GOstats or ontologyIndex in R, or goatools in Python

These tools can traverse the ontology graph and count all descendant (child) terms at any depth below the autophagy term.",,7.005716800689697,64,252,True,True,1.0,"Based on the results from the Ontology Lookup Service (OLS), the Gene Ontology term 'autophagy' (GO:0006914) has **25 descendant terms** in total.

The response shows 20 terms on the first page, with a total of 2 pages and 25 total elements. These descendants include various subtypes of autophagy such as:

- **Macroautophagy** (GO:0016236) and its subtypes like:
  - Mitophagy (autophagy of mitochondrion)
  - Pexophagy (autophagy of peroxisome)
  - Lipophagy (autophagy of lipid droplets)
  - Xenophagy (autophagy of pathogens)
  - Aggrephagy (autophagy of protein aggregates)
  - Reticulophagy (autophagy of ER)
  - And others

- **Microautophagy** (GO:0016237) and its subtypes
- **Chaperone-mediated autophagy** (GO:0061684)
- Other specialized forms

This hierarchical structure reflects the complexity of autophagic processes in cells, with each descendant term representing a more specific type or context of autophagy.",,17.14240598678589,8,438,13636,52275,mcp__ols__getDescendants,"[{""name"": ""mcp__ols__getDescendants"", ""input"": {""ontologyId"": ""go"", ""classIri"": ""http://purl.obolibrary.org/obo/GO_0006914""}}]",CRITICAL,25 descendant terms,"SIMPLE QUERY - Straightforward ontology navigation via API.

Method: OLS4 getDescendants API for GO:0006914

Demonstrates when baseline ontology tools suffice without complex SPARQL.

Verified in go_exploration.md simple queries section."
7,2026-02-01,Specificity,What genetic variants are associated with diabetes mellitus?,True,True,True,0.6153846153846154,"# Genetic Variants Associated with Diabetes Mellitus

Diabetes mellitus involves multiple genetic variants depending on the type:

## **Type 1 Diabetes (T1D)**
Primarily autoimmune with strong genetic components:

- **HLA region (chromosome 6p21)**: Strongest association
  - **HLA-DR3-DQ2** and **HLA-DR4-DQ8** haplotypes confer highest risk
  - **HLA-DR15-DQ6** is protective
  - Accounts for ~40-50% of genetic susceptibility

- **INS (insulin gene)**: VNTR polymorphisms in promoter region
- **PTPN22**: Protein tyrosine phosphatase variant (R620W)
- **CTLA4**: Immune regulation gene
- **IL2RA (CD25)**: Interleukin-2 receptor alpha chain

## **Type 2 Diabetes (T2D)**
Polygenic with over 400 associated loci identified:

- **TCF7L2**: Strongest common variant association (transcription factor)
- **PPARG**: Peroxisome proliferator-activated receptor gamma (Pro12Ala variant)
- **KCNJ11**: Potassium channel gene (E23K variant)
- **ABCC8**: Sulfonylurea receptor
- **IRS1**: Insulin receptor substrate-1
- **FTO**: Fat mass and obesity-associated gene
- **MC4R**: Melanocortin 4 receptor (obesity-related)
- **CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8**: Beta-cell function genes

## **Monogenic Diabetes**

- **MODY (Maturity-Onset Diabetes of the Young)**:
  - **HNF1A** (MODY3), **HNF4A** (MODY1), **GCK** (MODY2)
  - **HNF1B, PDX1, NEUROD1**, others

- **Neonatal diabetes**: **KCNJ11, ABCC8, INS** mutations

These variants affect insulin secretion, insulin action, beta-cell development, and glucose metabolism.",,10.316985130310059,47,539,True,True,0.6923076923076923,"Based on my search through PubMed and NCBI databases, here's a comprehensive overview of genetic variants associated with diabetes mellitus:

## Major Genetic Variants Associated with Diabetes Mellitus

### **Type 2 Diabetes (T2D) - Key Findings**

According to PubMed research, **over 400 genomic variants** have been identified as associated with Type 2 diabetes and related traits. A major genome-wide association study identified **143 risk variants** including 139 common and 4 rare variants, with 42 being independent of previously known variants ([DOI: 10.1038/s41467-018-04951-w](https://doi.org/10.1038/s41467-018-04951-w)).

### **Important Genes and Variants**

**1. ADIPOQ (Adiponectin) Gene:**
- **rs266729** and **rs17300539** in the promoter region are significantly associated with T2D risk
- Effects vary by population: rs266729 shows association in both Caucasian and Asian populations
- These variants affect adiponectin production, which plays a role in insulin sensitivity
([DOI: 10.1002/jcb.28572](https://doi.org/10.1002/jcb.28572))

**2. HNF4A (Hepatocyte Nuclear Factor 4 Alpha):**
- **rs1884613**, **rs2144908**, and **rs4810424** variants are associated with T2D risk
- This gene is crucial for pancreatic beta cell function and insulin secretion
([DOI: 10.1002/jcb.28572](https://doi.org/10.1002/jcb.28572))

**3. MTNR1B (Melatonin Receptor 1B):**
- **rs10830963** variant is significantly associated with T2D susceptibility
- Particularly strong association in South Asian populations
- Affects glucose metabolism through melatonin signaling
([DOI: 10.1002/mgg3.611](https://doi.org/10.1002/mgg3.611))

**4. Key Regulatory Genes Identified:**
- **CAMK1D** (Calcium/Calmodulin-Dependent Protein Kinase)
- **TP53INP1** (Tumor Protein p53 Inducible Nuclear Protein 1)
- **ATP5G1** (Mitochondrial ATP synthase)

These genes show evidence of epigenetic regulation where genetic variants affect T2D through gene expression changes ([DOI: 10.1038/s41467-018-04951-w](https://doi.org/10.1038/s41467-018-04951-w)).

### **Mechanistic Clusters**

A comprehensive clustering analysis identified **five distinct mechanistic pathways** for T2D variants ([DOI: 10.1371/journal.pmed.1002654](https://doi.org/10.1371/journal.pmed.1002654)):

1. **Beta cell dysfunction (low proinsulin)** - affecting insulin production
2. **Beta cell dysfunction (high proinsulin)** - impaired insulin processing
3. **Obesity-mediated insulin resistance** - high BMI and waist circumference
4. **Lipodystrophy-like pattern** - abnormal fat distribution with low adiponectin
5. **Liver lipid metabolism disruption** - affecting triglyceride levels

### **ClinVar Database**

The ClinVar database contains **over 25,000 genetic variants** associated with diabetes mellitus, representing a wide range of pathogenic and likely pathogenic variants across multiple genes.

### **Other Associated Genes**

From NCBI Gene database searches, other important genes implicated in diabetes include:
- **TP53** - involved in cellular stress response
- **IL6** - inflammatory cytokine linked to insulin resistance
- **TNF** - tumor necrosis factor, affects insulin signaling
- **APOE** - lipid metabolism
- **VEGFA** - vascular complications in diabetes

### **Clinical Implications**

According to PubMed research, while genetic risk scores can predict incident diabetes, **body mass index measurement remains more efficient** for detecting T2D risk groups in clinical practice. However, genetic sub-phenotyping may help personalize screening and treatment approaches ([DOI: 10.1007/s11892-019-1173-y](https://doi.org/10.1007/s11892-019-1173-y)).

### **Population Differences**

Genetic associations show significant variation across populations, with different effect sizes in Caucasian, Asian, and South Asian populations, highlighting the importance of ancestry-specific genetic studies.

This represents current knowledge based on genome-wide association studies, with ongoing research continuing to identify additional variants and refine our understanding of diabetes genetics.",,54.96480989456177,20,1673,28047,112758,"mcp__pubmed__search_articles, mcp__togomcp__ncbi_esearch, mcp__pubmed__get_article_metadata, mcp__togomcp__ncbi_esearch, mcp__togomcp__ncbi_esummary","[{""name"": ""mcp__pubmed__search_articles"", ""input"": {""query"": ""diabetes mellitus genetic variants"", ""max_results"": 20, ""sort"": ""relevance""}}, {""name"": ""mcp__togomcp__ncbi_esearch"", ""input"": {""database"": ""clinvar"", ""query"": ""diabetes mellitus"", ""max_results"": 20}}, {""name"": ""mcp__pubmed__get_article_metadata"", ""input"": {""pmids"": [""30860284"", ""31332628"", ""30240442"", ""30811895"", ""30054458""]}}, {""name"": ""mcp__togomcp__ncbi_esearch"", ""input"": {""database"": ""gene"", ""query"": ""diabetes mellitus AND (type 2 OR type 1) AND genetic variant"", ""max_results"": 20}}, {""name"": ""mcp__togomcp__ncbi_esummary"", ""input"": {""database"": ""gene"", ""ids"": [""7157"", ""1956"", ""348"", ""7124"", ""3569"", ""7422"", ""7040""]}}]",VALUABLE,"List of ClinVar variants associated with diabetes mellitus, including variants in genes such as INS, WFS1, KCNJ11, GCK","COMPLEX QUERY requiring cross-database knowledge.

Databases/Resources: ClinVar, MedGen

Knowledge Required:
- URI conversion between MedGen (www.ncbi.nlm.nih.gov) and ClinVar (ncbi.nlm.nih.gov)
- REPLACE function for URI pattern conversion
- VALUES pre-filtering for performance
- Property path through dct:references → rdfs:seeAlso

Without proper knowledge: Query returns 0 results due to URI namespace mismatch between databases.

Verified in clinvar_exploration.md Pattern 2 (MedGen Disease Integration)."
8,2026-02-01,Specificity,What is the MONDO disease ontology identifier for Fabry disease?,True,True,True,1.0,"The MONDO (Monarch Disease Ontology) identifier for Fabry disease is **MONDO:0010526**.

Fabry disease is an X-linked lysosomal storage disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of globotriaosylceramide in various tissues.",,3.137782096862793,52,79,True,True,1.0,"The MONDO disease ontology identifier for Fabry disease is **MONDO:0010526**.

According to the MONDO ontology, Fabry disease is defined as ""a progressive, inherited, multisystemic lysosomal storage disease characterized by specific neurological, cutaneous, renal, cardiovascular, cochleo-vestibular and cerebrovascular manifestations.""",,14.214703798294067,8,185,17026,52263,mcp__ols__searchClasses,"[{""name"": ""mcp__ols__searchClasses"", ""input"": {""query"": ""Fabry disease"", ""ontologyId"": ""mondo""}}]",VALUABLE,MONDO:0010526,"SIMPLE QUERY - Straightforward ontology term lookup.

Method: OLS4 searchClasses for 'Fabry disease' in MONDO ontology

Demonstrates when basic ontology search tools suffice.

Verified in example_questions.json question 2."
9,2026-02-01,Currency,What pathogenic variants were recently added to ClinVar?,True,False,True,0.5333333333333333,"I don't have access to real-time data or the ability to query ClinVar directly, so I cannot tell you which specific pathogenic variants were recently added to the database.

To find recently added pathogenic variants in ClinVar, you would need to:

1. **Visit the ClinVar website** (https://www.ncbi.nlm.nih.gov/clinvar/)

2. **Use the search filters** to:
   - Filter by ""Clinical significance"" = Pathogenic
   - Sort by ""Date last updated"" or ""Date first in ClinVar""
   - Specify a recent time frame

3. **Check ClinVar's FTP site** for monthly release notes, which often highlight new submissions

4. **Use the ClinVar API or download** the latest VCF files to compare against previous versions

ClinVar is continuously updated with new submissions from clinical laboratories, research groups, and expert panels worldwide, so new pathogenic variants are added regularly—often hundreds or thousands per month.

If you're looking for specific genes, conditions, or need recent updates for clinical or research purposes, I'd recommend checking the database directly or setting up automated alerts for variants of interest.",,7.170363187789917,49,263,True,False,0.3333333333333333,"Based on the ClinVar database search, here are some of the **most recently added pathogenic and likely pathogenic variants** (evaluated in January 2026 and late 2025):

## Recent Pathogenic Variants

### 1. **TRPM6 gene - VCV004686645**
- **Variant**: c.1966dup (p.His656fs)
- **Type**: Frameshift (duplication)
- **Classification**: Pathogenic
- **Evaluated**: January 22, 2026
- **Associated condition**: Intestinal hypomagnesemia 1 (OMIM #602014)
- **Location**: Chromosome 9

### 2. **TIMM8A gene - VCV004686644**
- **Variant**: c.58C>T (p.Gln20Ter)
- **Type**: Nonsense (stop-gain)
- **Classification**: Pathogenic
- **Evaluated**: January 22, 2026
- **Associated condition**: Deafness dystonia syndrome (OMIM #304700)
- **Location**: Chromosome X

### 3. **DICER1 gene - Multiple variants**
Several pathogenic and likely pathogenic variants in DICER1 associated with **DICER1-related tumor predisposition syndrome**:

- **c.1052del** (p.Phe351fs) - Pathogenic, frameshift
- **c.3700G>T** (p.Glu1234Ter) - Pathogenic, nonsense
- **c.3282dup** (p.Asp1095fs) - Pathogenic, frameshift
- **c.4786del** (p.Arg1596fs) - Pathogenic, frameshift
- **c.2222del** (p.Gly741fs) - Likely pathogenic, frameshift
- **c.3041T>G** (p.Leu1014Ter) - Likely pathogenic, nonsense
- **c.3242del** (p.Gly1081fs) - Likely pathogenic, frameshift
- **c.202_205delinsAA** (p.Ser68fs) - Likely pathogenic, indel

All DICER1 variants were evaluated in December 2025 and are located on **Chromosome 14**.

## Key Patterns
- Most recent variants are **loss-of-function mutations** (frameshift, nonsense)
- Several are associated with **rare genetic disorders** and **tumor predisposition syndromes**
- All have been evaluated within the last 1-2 months with single submitter evidence

These variants represent the newest additions to ClinVar's database of clinically significant genetic variations.",,37.58087110519409,18,1113,12894,105861,"mcp__togomcp__ncbi_esearch, mcp__togomcp__ncbi_efetch, mcp__togomcp__ncbi_esummary","[{""name"": ""mcp__togomcp__ncbi_esearch"", ""input"": {""database"": ""clinvar"", ""query"": ""pathogenic[Clinical significance] OR likely pathogenic[Clinical significance]"", ""max_results"": 20, ""sort_by"": ""pub_date""}}, {""name"": ""mcp__togomcp__ncbi_efetch"", ""input"": {""database"": ""clinvar"", ""ids"": [""4686645"", ""4686644"", ""4686640"", ""4686639"", ""4686638"", ""4686637"", ""4686636"", ""4686635"", ""4686634"", ""4686633""], ""rettype"": ""vcv"", ""retmode"": ""xml""}}, {""name"": ""mcp__togomcp__ncbi_esummary"", ""input"": {""database"": ""clinvar"", ""ids"": [""4686645"", ""4686644"", ""4686640"", ""4686639"", ""4686638"", ""4686637"", ""4686636"", ""4686635"", ""4686634"", ""4686633""]}}]",CRITICAL,"List of recently submitted pathogenic variants with their genes and dates, examples include variants in BTK, GRN, PAX2, PKD1 genes","COMPLEX QUERY requiring date filtering knowledge.

Databases/Resources: ClinVar

Knowledge Required:
- Date filtering with cvo:date_created >= date
- Property path for clinical significance
- record_status 'current' filter
- xsd:date type for date comparison

Without proper knowledge: Incorrect date comparisons or missing significance path.

Verified in clinvar_exploration.md Pattern 7 (Recently Updated Variants)."
10,2026-02-01,Currency,What biochemical pathways in Reactome database involve mTOR signaling?,True,False,True,0.8333333333333334,"I don't have access to real-time database queries or the ability to search the Reactome database directly. However, based on my training knowledge, I can tell you about major biochemical pathways involving mTOR signaling that are typically documented in Reactome and similar pathway databases:

## Key mTOR-related pathways:

1. **mTOR signaling pathway** - The core pathway showing mTOR complex formation and activation

2. **mTORC1 signaling** - Including:
   - Amino acid sensing and signaling
   - Growth factor signaling (PI3K/AKT pathway)
   - Regulation of protein synthesis (S6K and 4E-BP1 phosphorylation)
   - Autophagy regulation

3. **mTORC2 signaling** - Including:
   - AKT phosphorylation at Ser473
   - Regulation of cytoskeletal organization
   - Cell survival signaling

4. **Insulin/IGF signaling** - mTOR as a downstream effector

5. **PI3K/AKT signaling pathway** - Where mTOR serves as a key node

6. **Amino acid metabolism and sensing** - Particularly leucine sensing

7. **Autophagy regulation** - mTOR-mediated suppression of autophagy

8. **Energy sensing pathways** - AMPK-mTOR interactions

To get the exact current list of pathways in Reactome involving mTOR, I'd recommend visiting the Reactome website (reactome.org) and searching for ""mTOR"" directly in their database.",,8.151323318481445,54,372,True,True,0.75,"Based on the Reactome database search, here are the **biochemical pathways involving mTOR signaling**:

## Primary mTOR Pathways (Human)

1. **MTOR signalling** (R-HSA-165159)
   - The main pathway encompassing mTOR signaling activities

2. **Energy dependent regulation of mTOR by LKB1-AMPK** (R-HSA-380972)
   - This pathway shows how cellular energy status regulates mTOR through the LKB1-AMPK axis

## Related Pathways with mTOR Involvement

3. **Signaling by Hippo** (R-HSA-2028269)
   - The Hippo pathway interacts with mTOR signaling

4. **Signaling by Interleukins** (R-HSA-449147)
   - Interleukin signaling pathways that connect to mTOR

## Key mTOR Complexes Identified

The search also revealed several important **mTOR protein complexes**:

- **mTORC1** (Mechanistic Target of Rapamycin Complex 1)
  - Active mTORC1 complex (R-HSA-165678)
  - Various mTORC1 complexes with regulatory proteins (RPTOR, Ragulator, Rag, RHEB)

- **mTORC2** (TORC2 complex) (R-HSA-198626)
  - Involved in phosphorylating AKT at S473

## Notable Reactions

- **TORC2 (mTOR) phosphorylates AKT at S473** (R-HSA-198640)
  - A critical downstream signaling event for cell survival and growth

These pathways are conserved across multiple species including mouse, rat, zebrafish, and other model organisms, highlighting the fundamental importance of mTOR signaling in cellular metabolism, growth, and survival.",,20.900685787200928,9,565,6108,52265,mcp__togomcp__search_reactome_entity,"[{""name"": ""mcp__togomcp__search_reactome_entity"", ""input"": {""query"": ""mTOR signaling"", ""rows"": 30}}]",CRITICAL,"Multiple pathways including mTOR signaling, nutrient sensing, autophagy regulation, and related signaling pathways","COMPLEX QUERY requiring pathway database knowledge.

Databases/Resources: Reactome

Knowledge Required:
- Reactome entity model for pathways
- Species filtering for human pathways
- Keyword search across pathway names and descriptions
- Understanding of pathway hierarchy

Without proper knowledge: Cannot effectively filter or navigate pathway relationships.

Verified through Reactome search capabilities and exploration."
11,2026-02-01,Precision,What is the UniProt accession number for human tumor protein p53?,True,True,True,1.0,"The UniProt accession number for human tumor protein p53 is **P04637**.

This is the primary accession number for the TP53 gene product, which is one of the most well-studied tumor suppressor proteins in humans.",,2.762758731842041,53,56,True,True,1.0,"The UniProt accession number for human tumor protein p53 is **P04637**.

This protein is also known as:
- Cellular tumor antigen p53
- Antigen NY-CO-13
- Phosphoprotein p53
- Tumor suppressor p53

P04637 is the canonical entry for the human TP53 gene product in UniProt.",,11.955639123916626,9,194,664,52264,mcp__togomcp__search_uniprot_entity,"[{""name"": ""mcp__togomcp__search_uniprot_entity"", ""input"": {""query"": ""human tumor protein p53"", ""limit"": 5}}]",VALUABLE,P04637,"SIMPLE QUERY - Straightforward protein lookup.

Method: search_uniprot_entity('human p53')

Demonstrates when basic protein search tools suffice.

Verified in uniprot_exploration.md simple queries section."
12,2026-02-01,Precision,How many protein crystal structures in the PDB have resolution better than 2.0 Angstroms?,True,False,True,1.0,"I don't have access to real-time PDB statistics, so I cannot give you the current exact number. However, I can provide some context:

As of my training data (with knowledge up to early 2024), there were **well over 100,000 protein crystal structures** in the Protein Data Bank (PDB) with resolution better than 2.0 Angstroms. This represents a substantial portion of all X-ray crystal structures in the PDB.

To get the current exact number, you would need to:
1. Visit the PDB website (rcsb.org or pdbe.org)
2. Use their advanced search interface
3. Filter by:
   - Experimental method: X-ray crystallography
   - Resolution: ≤ 2.0 Å
   - Molecule type: Protein

The number continuously grows as new structures are deposited regularly. High-resolution structures (better than 2.0 Å) are quite common for well-ordered protein crystals, as modern synchrotron facilities and improved crystallization techniques have made such resolutions increasingly achievable.",,6.770832061767578,60,249,True,True,1.0,"Perfect! According to the PDB database query, there are **77,916 protein crystal structures** with resolution better than (less than) 2.0 Angstroms.

This count includes structures determined by X-ray crystallography/diffraction methods that have a high-resolution limit better than 2.0 Å, which is considered high-resolution for protein crystallography. Such high-resolution structures allow for detailed visualization of atomic positions, water molecules, and side chain conformations.",,26.57616901397705,15,938,1219,79000,"mcp__togomcp__run_sparql, mcp__togomcp__run_sparql","[{""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""pdb"", ""sparql_query"": ""\nPREFIX rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX pdbo: <http://rdf.wwpdb.org/schema/pdbx-v50.owl#>\n\nSELECT (COUNT(DISTINCT ?entry) AS ?count)\nWHERE {\n  ?entry rdf:type pdbo:datablock .\n  ?entry pdbo:has_refineCategory ?refine .\n  ?refine pdbo:has_refine ?refine_details .\n  ?refine_details pdbo:refine.ls_d_res_high ?resolution .\n  \n  ?entry pdbo:has_exptlCategory ?exptl_cat .\n  ?exptl_cat pdbo:has_exptl ?exptl .\n  ?exptl pdbo:exptl.method ?method .\n  \n  FILTER(?resolution < 2.0)\n  FILTER(CONTAINS(LCASE(?method), \""x-ray\"") || CONTAINS(LCASE(?method), \""diffraction\""))\n}\n""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""pdb"", ""sparql_query"": ""\nPREFIX rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX pdbo: <http://rdf.wwpdb.org/schema/pdbx-v50.owl#>\nPREFIX xsd: <http://www.w3.org/2001/XMLSchema#>\n\nSELECT (COUNT(DISTINCT ?entry) AS ?count)\nWHERE {\n  ?entry rdf:type pdbo:datablock .\n  ?entry pdbo:has_refineCategory ?refine_cat .\n  ?refine_cat pdbo:has_refine ?refine .\n  ?refine pdbo:refine.ls_d_res_high ?resolution_literal .\n  \n  ?entry pdbo:has_exptlCategory ?exptl_cat .\n  ?exptl_cat pdbo:has_exptl ?exptl .\n  ?exptl pdbo:exptl.method ?method .\n  \n  BIND(xsd:float(?resolution_literal) AS ?resolution)\n  \n  FILTER(?resolution < 2.0)\n  FILTER(CONTAINS(LCASE(STR(?method)), \""x-ray\"") || CONTAINS(LCASE(STR(?method)), \""diffraction\""))\n}\n""}}]",CRITICAL,"77,877 X-ray structures with resolution < 2.0 Å","COMPLEX QUERY requiring numeric type conversion knowledge.

Databases/Resources: PDB

Knowledge Required:
- xsd:decimal() conversion CRITICAL - resolution stored as string
- Without conversion, string comparison '1.5' < '2.0' fails silently returning 0 results
- Must use FILTER(xsd:decimal(?resolution) > 0 && xsd:decimal(?resolution) < 2.0)
- Experimental method filter for X-ray diffraction

Without proper knowledge: Query returns 0 results due to string vs numeric comparison failure.

Verified in pdb_exploration.md Pattern 1 (Numeric Type Conversion for Resolution Filtering)."
